Medicine for treating pulmonary tuberculosis

Abstract

The invention provides medicine for treating pulmonary tuberculosis. The medicine is characterized by comprising, by weight, 15-20 parts of radix glycyrrhizae, 10-15 parts of angelica sinensis, 25-35 parts of fritillaria cirrhosa, 9-20 parts of pericarpium citri reticulatae, 20-30 parts of poria cocos, 10-20 parts of rhizoma atractylodis macrocephalae, 15-30 parts of rhizoma chuanxiong, 20-30 parts of white mulberry root-bark, 20-30 parts of schisandra chinensis, 10-20 parts of pinellia ternate, 20-30 parts of rhizoma anemarrhenae, 25-35 parts of endothelium corneum gigeriae galli, 5-15 parts of Chinese azalea flowers, 20-30 parts of wideleaf osbeckia roots, 45-55 parts of radix stemonae, 45-55 parts of rhizoma bletillae, 20-30 parts of radix scutellariae, 25-35 parts of rhizoma polygonati, 45-55 parts of honey, 45-55 parts of apricot kernels, 90-110 parts of coix lachryma-jobi kernels, 90-110 parts of lycium barbarum, 90-110 parts of lily, 90-110 parts of semen ginkgo, 45-55 parts of panax notoginseng, 45-55 parts of geckoes, 200-250 parts of cucumber seeds, 200-250 parts of spinach seeds, 8-15 parts of asparagus cochinchinensis, 10-15 parts of common selfheal fruit-spike, 15-20 parts of hedyotis diffusa, 30-50 parts of radix astragali, 20-30 parts of agarwood, 200-300 parts of yali pears, 20-30 parts of radix ophiopogonis, 15-20 parts of radix rehmanniae, 25-35 parts of cogongrass rhizome, 30-40 parts of herba andrographitis, 20-30 parts of cortex lycii radicis, 20-25 parts of Chinese hooly leaves and 25-35 parts of radix glehniae.

Description

technical field [0001] The invention relates to a medicine for treating tuberculosis, in particular to a traditional Chinese medicine composition for treating tuberculosis. Background technique [0002] Pulmonary tuberculosis (PTB) is a pulmonary infectious disease caused by Mycobacterium tuberculosis. It is a disease that seriously threatens human health. The source of infection of Mycobacterium tuberculosis (abbreviated as Mycobacterium tuberculosis, the same below) is mainly tuberculosis patients who excrete bacteria, and it is transmitted through the respiratory tract. Healthy people infected with tuberculosis do not necessarily have the disease, only when the body's immunity is weakened. Statistics from the World Health Organization (WHO) show that 8-10 million cases of tuberculosis occur every year in the world, and about 3 million people die from tuberculosis every year. It is the single infectious disease that causes the largest number of deaths. In 1993, WHO de...

AI Technical Summary

Problems solved by technology

[0006] At present, the drugs used for pulmonary tuberculosis are generally: isoniazid, rifampicin, ethambutol, pyrazinamide, streptomycin, etc., but these western medicines are prone to drug resistance and cannot achieve the curative effect. There are problems such as slow effect of traditional Chinese medicine